In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kyowa Kirin Co., Ltd.

https://www.kyowakirin.com/

Latest From Kyowa Kirin Co., Ltd.

Deal Watch: J&J Begins 2022 With Trio Of Technology Alliances

Heading into the J.P. Morgan Healthcare conference, pharmas have been focusing on discovery alliances. J&J’s deals look into novel tissue-targeted drugs, ionic liquid delivery technology and cancer vaccine R&D. Lilly teams with Entos on novel methods for delivering neurology drugs.

Deal Watch Business Strategies

Evrysdi & Tagrisso Among Myriad Products To Win English Funding

Roche’s oral treatment for spinal muscular atrophy and AstraZeneca’s non-small-cell lung cancer drug are among a number of medicines to get the thumbs up from the health technology assessment body, NICE.

United Kingdom Cost Effectiveness

Finance Watch: Biopharma IPOs Slow But SPACs Back On The Go

Public Company Edition: It has been almost a month since a biopharma firm launched an IPO in the US, but special purpose acquisition corporations continue to take drug makers public, including Alvotech and Aerami. Outside the US, MaaT closed an IPO in Paris and BeiGene priced a Shanghai offering.

Financing Business Strategies

ASH Preview: Three Areas To Watch In Hematology-Oncology

Novartis hopes a CAR-T with rapid manufacturing will be a winner, while novel bispecific antibodies in lymphoma and myeloma will make appearances, along with next-generation PI3K and BTK inhibitors.

Cancer Clinical Trials
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Pharmaceuticals
    • Nutraceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Other Names / Subsidiaries
    • Archimedes Pharma Ltd.
    • Centus Biotherapeutics Ltd.
    • Daiichi Fine Chemical Co., Ltd.
    • Fujifilm Kyowa Kirin Biologics Co., Ltd.
    • Kirin Pharma Company, Limited
    • Kyowa Kirin Asia Pacific Pte. Ltd.
    • Kyowa Kirin Australia Pty Ltd
    • Kyowa Kirin International PLC
    • Kyowa Pharma Chemical Co., Ltd.
    • ProStrakan Group plc
    • Kyowa Kirin
    • Kyowa Kirin Frontier Co., Ltd.
    • Kyowa Hakko Kirin (Singapore) Pte. Ltd.
    • Kyowa Hakko Kirin Co., Ltd.
UsernamePublicRestriction

Register